The content on this site is intended for healthcare professionals only
Prof Frederique Penault-Llorca spoke to ecancer at the BGICC 2020 conference in Cairo, Egypt about BRCA testing in breast and ovarian cancer.
She highlights the tests and procedures that are used, but also the strategy used to better connect testing at the stage of diagnosis or recurrence.
Prof Penault-Llorca emphasises that people should think about BRCA testing even without a family history of breast cancer.
ASCO 2026: Latest updates in mRCC
SABCS 2025: Latest developments in multigene testing in early breast cancer
AI-Based sTIL analysis expands identification of HER2+ BC patients benefiting from pertuzumab
The added value of integrative medicine
Insights into germline genetic screening of breast cancer patients
ESMO 2024: Optimising the personalisation of prostate cancer treatment
SABCS 2023: Latest breast cancer diagnostics guidelines
Genomic testing: Awareness and effective communication between healthcare professionals and patients
Short-course radiation as effective as standard treatment for breast cancer patients choosing reconstruction after mastectomy
